Robert Lustig, MD: Genetics play a role in Non-Alcoholic Fatty Liver Disease #shorts #sugar #food
Short transcript discussing genetic contributors to non-alcoholic fatty liver disease (NAFLD), noting that two polymorphisms—PNPLA3 and SLC16A11—common in Latinos increase triglyceride synthesis and conversion of fructose to liver fat, so small amounts of sugar can produce substantial liver fat. The speaker states about 18% of Latinos carry these risk variants.
Questions this video answers
PNPLA3 (patatin-like phospholipase domain containing 3) and SLC16A11.
About 18% of Latinos.
They increase conversion of fructose to liver fat and promote triglyceride synthesis, so small amounts of sugar can produce a lot of liver fat.
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet